Physician profile
Peter B Maurus
NPI 1881602050
$17,088.28
in general payments reported to CMS, 2019-2025
8 companies · $739 in 2025
The $739 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,068 · 2020: $14.00 · 2022: $2,568 · 2023: $11K · 2024: $1,842 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,978 · Travel and Lodging: $5,535 · Food and Beverage: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,978.21 |
| Travel and Lodging | $5,535.32 |
| Food and Beverage | $924.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $7,070.03 | 2023 | |
| Stryker Corporation | $6,833.53 | 2022-2025 | Infinity, Inbone, Invision |
| Synthes USA Products LLC | $1,773.36 | 2023 | |
| Wright Medical Technology, INC. | $1,068.23 | 2019 | |
| Wardlow Enterprises | $203.59 | 2022-2023 | |
| Organogenesis INC. | $82.91 | 2023-2024 | Puraply |
| International Life Sciences | $42.63 | 2024 | Flexband |
| Arthrex, INC. | $14.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Maurus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.